Aug 5, 2024, 10:33
Experts in multiple myeloma discuss exciting updates presented at the 2024 ASCO Annual Meeting – Cancer Network
Cancer Network shared on LinkedIn:
“Experts in multiple myeloma look to the future treatment landscape and discuss exciting updates presented at the 2024 ASCO Annual Meeting, highlighting belantamab mafodotin and combination therapies.”
Source: Cancer Network/LinkedIn
Aug 5, 2024, 10:09